Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Hematology
Reference36 articles.
1. Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy;Muul;J Immunol Methods,1987
2. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity;Schmidt-Wolf;J Exp Med,1991
3. Whom to Trust When Sick? The Wei Zexi incident, the Chinese internet, and the healthcare system in China;Li;China Perspectives,2016
4. The landscape of CAR T-cell therapy in the United States and China: a comparative analysis;Gou;Int J Cancer,2019
5. CAR-T therapy in clinical practice: technical advances and current challenges;Ren;Adv Biol (Weinh),2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards;Cytotherapy;2024-08
2. Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma;Chinese Medical Journal;2024-04-03
3. Improving the safety of CAR‐T‐cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B‐cell lymphoma undergoing CAR‐T‐cell therapy;American Journal of Hematology;2024-01-10
4. Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era;Experimental Hematology & Oncology;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3